Intellectual Property India Publishes Patent Application for 'A Process For Ai-Guided Drug Repurposing Using Cellular Models' Filed by Graphic Era

MUMBAI, India, Jan. 8 -- Intellectual Property India has published a patent application (202511102574 A) filed by Graphic Era, Dehradun, Uttarakhand, on Oct. 24, 2025, for 'a process for ai-guided drug repurposing using cellular models.'

Inventor(s) include Deependra Pratap Singh.

The application for the patent was published on Dec. 12, under issue no. 50/2025.

According to the abstract released by the Intellectual Property India: "The invention discloses a process for AI-guided drug repurposing using cellular models comprising a drug compound database (101), AI prediction module (102), cellular model screening unit (103), validation analytics engine (104), and output repository (105). The system predicts new therapeutic indications for existing drugs, validates them through cellular assays, and refines predictions via feedback integration, enabling faster, cost-efficient, and biologically reliable drug repositioning."

Disclaimer: Curated by HT Syndication.